Object Trading Rolls Out DMA for CurveGlobal Launch

London Stock Exchange's interest-rate derivatives venue is due to launch next week following delay earlier this year

London Stock Exchange

Object Trading will provide its DMA platform, a single gateway for normalized market data and order execution, for users to gain immediate access to the venue, similarly to services provided for the Australian Stock Exchange (ASX).

Originally announced in October 2015, the dedicated venue for interest-rate swaps, jointly owned by the London Stock Exchange (LSEG), seven major dealer banks and the Chicago Board Options Exchange (CBOE) was delayed until September this year to "ensure customer readiness."

"In addition to partnering with top-tier banks, we are working with technology firms like Object Trading, which are dedicated to enhancing market liquidity and already have a community of firms making markets around the world," said CurveGlobal CEO, Andy Ross, in a statement. "Today's news will make it easier for traders to provide liquidity on CurveGlobal from day one and with Object Trading's direct market access platform, this community can get immediate access to CurveGlobal."

Ross spoke to WatersTechnology about the CurveGlobal platform in more detail in a recent Waters Wavelength podcast.

 

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Waters Wrap: The tough climb for startups

Anthony speaks with two seasoned technologists to better understand why startups have such a tough time getting banks and asset managers to sign on the dotted line.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here